Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Improving the Stratification of Risks of Conversion of Radiologically Isolated Syndromes (RIS) by Identifying Biomarkers in Serum and Cerebrospinal Fluid. The ProBioRIS Study

NCT06395662 is registered in ClinicalTrials.gov with Centre Hospitalier Universitaire de Nīmes as lead sponsor.

NCT NCT06395662
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06395662 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Improving the Stratification of Risks of Conversion of Radiologically Isolated Syndromes (RIS) by Identifying Biomarkers in Serum and Cerebrospinal Fluid. The ProBioRIS Study
Lead sponsor
Centre Hospitalier Universitaire de Nīmes
Phase
Observational
Overall status
Completed
Start date
April 15, 2024
Completion date
July 25, 2025
Enrollment
320 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

multiple sclerosis, radiologically isolated syndrome